These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook. J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318 [No Abstract] [Full Text] [Related]
3. Key factors impacting the delivery and financing of oncology care in the United States. Goldsmith PJ; Paivanas T J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607 [No Abstract] [Full Text] [Related]
4. American Society of Clinical Oncology guidance statement: the cost of cancer care. Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE; J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533 [TBL] [Abstract][Full Text] [Related]
5. Introduction and commentary: Paving the way for biosimilars in oncology. Abraham J Semin Oncol; 2013 Dec; 40 Suppl 1():S1-4. PubMed ID: 24267943 [No Abstract] [Full Text] [Related]
6. Improving cancer research. Leaders cite collaboration and increased areas of study as ways to fight the disease. Printz C Cancer; 2013 May; 119(10):1765-6. PubMed ID: 23649487 [No Abstract] [Full Text] [Related]
7. Are we winning the war on cancer? Okon T; Schwartzberg L Am J Manag Care; 2012 Feb; 18(1 Spec No.):SP10-1. PubMed ID: 22468865 [No Abstract] [Full Text] [Related]
8. Seeking value as cancer drug costs soar. Bender E Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760 [TBL] [Abstract][Full Text] [Related]
9. Science and society: Fifty years later--the 2014 presidential address. Hudis CA J Clin Oncol; 2015 Jan; 33(2):127-32. PubMed ID: 25452454 [No Abstract] [Full Text] [Related]
10. [Future cancer care challenges the health care]. Olofsson S Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702 [No Abstract] [Full Text] [Related]
11. Innovative oncology products: time to revisit the strategy development? Krendyukov A ESMO Open; 2019; 4(5):e000571. PubMed ID: 31749992 [No Abstract] [Full Text] [Related]
12. Personalized cancer therapy--the key to the future. Sikora K Pharmacogenomics; 2004 Apr; 5(3):225-8. PubMed ID: 15102537 [No Abstract] [Full Text] [Related]
13. Cancer research in the United States: A critical review of current status and proposal for alternative models. Kantarjian HM; Prat F; Steensma DP; Kurzrock R; Stewart DJ; Sekeres MA; Leveque J Cancer; 2018 Jul; 124(14):2881-2889. PubMed ID: 29757456 [No Abstract] [Full Text] [Related]
14. Cost of cancer care: issues and implications. Meropol NJ; Schulman KA J Clin Oncol; 2007 Jan; 25(2):180-6. PubMed ID: 17210937 [TBL] [Abstract][Full Text] [Related]
15. Good news. Block KI Integr Cancer Ther; 2012 Dec; 11(4):291-2. PubMed ID: 23160254 [No Abstract] [Full Text] [Related]
16. Deal-making trends in oncology. Moore K; Walker J Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466 [No Abstract] [Full Text] [Related]
17. The war on cancer: progress at what price? Konski A J Clin Oncol; 2011 Apr; 29(12):1503-4. PubMed ID: 21402613 [No Abstract] [Full Text] [Related]
18. Oncology in the era of managed care. Gerszten PC J Oncol Manag; 1998; 7(3):21-3. PubMed ID: 10181577 [TBL] [Abstract][Full Text] [Related]
19. Is high and growing spending on cancer treatment and prevention harmful to the United States economy? Pauly MV J Clin Oncol; 2007 Jan; 25(2):171-4. PubMed ID: 17210935 [No Abstract] [Full Text] [Related]
20. Collaborative Practice in an Era of Multidisciplinary Care. Kosty MP; Pickard T; Viale P Am Soc Clin Oncol Educ Book; 2016; 35():3-8. PubMed ID: 27249679 [No Abstract] [Full Text] [Related] [Next] [New Search]